Veramyst and Azithromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veramyst (fluticasone furoate) and Azithromycin (azithromycin). Common drug interactions include weight decreased among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Veramyst and Azithromycin. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Veramyst?

Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

68 people who take Veramyst and Azithromycin together, and have interactions are studied.

Veramyst and Azithromycin drug interactions.

What are the common drug interactions of Veramyst and Azithromycin, by gender? *:

female:

  1. Weight decreased
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Swelling
  4. Abasia (inability to walk)
  5. Abdominal pain
  6. Anxiety
  7. Asthma
  8. Cellulitis (infection under the skin)
  9. Chlamydial infection (a common sexually transmitted infection (sti) in humans caused by the bacterium chlamydia trachomatis)
  10. Cholecystitis (infection of gallbladder)

male:

  1. Emotional distress
  2. Pain
  3. Gait disturbance
  4. General physical health deterioration (weak health status)
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Mobility decreased (ability to move is reduced)
  8. Oropharyngeal pain
  9. Renal failure (kidney dysfunction)
  10. Renal tubular necrosis (death of kidney tubules)

What are the common drug interactions of Veramyst and Azithromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the)
  2. Abdominal pain
  3. Cholecystitis (infection of gallbladder)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
  6. Chest pain
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Pain
  10. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

20-29:

  1. Anaemia (lack of blood)
  2. Asthenia (weakness)
  3. Conjunctivitis viral (infection of conjunctiva by virus)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Food poisoning (poison in food)
  6. Insomnia (sleeplessness)
  7. Keloid scar (overgrown scars left from skin injuries)
  8. Nausea (feeling of having an urge to vomit)
  9. Urinary tract infection
  10. Vomiting

30-39:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Pain
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Abasia (inability to walk)
  5. Oedema peripheral (superficial swelling)
  6. Pulmonary thrombosis (scarring in the lungs)
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Arthralgia (joint pain)
  9. Swelling
  10. Chest pain

40-49:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Deformity (disfigurement)
  3. Emotional distress
  4. Erythema (redness of the skin)
  5. Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the)
  6. Gangrene (body tissue dies)
  7. Genital abscess (build up of pus in genital)
  8. Groin abscess (pus in groin)
  9. Injury
  10. Leukocytosis (increased white blood cells)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Exercise tolerance decreased
  6. Gait disturbance
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Pain

60+:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Blood creatinine increased
  3. Renal tubular necrosis (death of kidney tubules)
  4. Tetany (involuntary contraction of muscles)
  5. Acidosis (build-up of carbon dioxide in the blood)
  6. Activities of daily living impaired
  7. Ageusia (loss of taste functions of the tongue)
  8. Anosmia (partial or complete loss of the sense of smell)
  9. Anxiety
  10. Aphasia (damage to the parts of the brain that control language)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 29.41%
  2. Depression: 15 people, 22.06%
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 15 people, 22.06%
  4. High Blood Pressure: 15 people, 22.06%
  5. Cough: 15 people, 22.06%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 14 people, 20.59%
  7. Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 14 people, 20.59%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 14 people, 20.59%
  9. Incontinence (lack of moderation or self-control): 14 people, 20.59%
  10. Indigestion: 14 people, 20.59%

* Approximation only. Some reports may have incomplete information.

Do you take Veramyst and Azithromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veramyst and Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veramyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veramyst and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and azithromycin (the active ingredients of Veramyst and Azithromycin, respectively), and Veramyst and Azithromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: